Manesh R Patel Selected Research

Enzyme Replacement Therapy

1/2016	Time to treatment benefit for adult patients with Fabry disease receiving agalsidase β: data from the Fabry Registry.
1/2016	Risk factors for severe clinical events in male and female patients with Fabry disease treated with agalsidase beta enzyme replacement therapy: Data from the Fabry Registry.
3/2011	Cardiovascular events in patients with fabry disease natural history data from the fabry registry.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Manesh R Patel Research Topics

Disease

86	Myocardial Infarction 12/2023 - 07/2004
84	Stroke (Strokes) 01/2024 - 06/2008
73	Hemorrhage 02/2024 - 09/2011
70	Atrial Fibrillation 01/2024 - 06/2008
67	Peripheral Arterial Disease 05/2024 - 01/2006
51	Embolism (Embolus) 01/2023 - 06/2008
29	ST Elevation Myocardial Infarction 02/2024 - 01/2009
28	Heart Failure 01/2023 - 09/2009
27	Ischemia 01/2024 - 12/2004
23	Ischemic Stroke 12/2023 - 09/2011
22	Infarction (Infarctions) 01/2022 - 12/2004
19	Coronary Artery Disease (Coronary Atherosclerosis) 05/2024 - 03/2010
19	Cardiovascular Diseases (Cardiovascular Disease) 03/2023 - 11/2009
16	Hypertension (High Blood Pressure) 01/2024 - 06/2006
15	Acute Coronary Syndrome 01/2022 - 01/2002
12	Diabetes Mellitus 01/2024 - 11/2012
10	Pathologic Constriction (Stenosis) 01/2024 - 02/2012
8	Thrombosis (Thrombus) 01/2023 - 06/2008
8	Intracranial Hemorrhages (Intracranial Hemorrhage) 10/2021 - 09/2011
7	Cardiogenic Shock 01/2020 - 09/2011
7	Coronary Disease (Coronary Heart Disease) 01/2018 - 01/2002
6	Chronic Limb-Threatening Ischemia 06/2022 - 09/2012
5	Transient Ischemic Attack 01/2022 - 09/2009
5	Chest Pain (Chest Pains) 11/2021 - 06/2005
4	Type 2 Diabetes Mellitus (MODY) 01/2024 - 12/2019
4	Peripheral Vascular Diseases (Peripheral Vascular Disease) 01/2023 - 11/2014
4	Infections 01/2022 - 07/2012
4	Anemia 12/2021 - 09/2009
4	Shock 08/2021 - 11/2009
4	Chronic Obstructive Pulmonary Disease (COPD) 01/2021 - 05/2013
4	Inflammation (Inflammations) 12/2020 - 11/2008
4	Intermittent Claudication 01/2019 - 01/2014
4	Fabry Disease (Fabry's Disease) 01/2016 - 03/2011
3	Pain (Aches) 01/2024 - 01/2002
3	Coronary Stenosis (Coronary Artery Stenosis) 10/2022 - 01/2018
3	Unstable Angina 01/2022 - 01/2002
3	COVID-19 01/2022 - 12/2020
3	Vascular Diseases (Vascular Disease) 12/2021 - 01/2018
3	Chronic Renal Insufficiency 12/2021 - 01/2016
3	Myocardial Ischemia (Ischemic Heart Diseases) 11/2020 - 12/2004
3	Hemorrhagic Stroke 01/2019 - 07/2013
3	Overweight 01/2017 - 04/2004
2	Atherosclerosis 01/2024 - 09/2012
2	Cardiomyopathies (Cardiomyopathy) 01/2024 - 01/2022
2	Body Weight (Weight, Body) 01/2024 - 01/2017
2	Hyperlipidemias (Hyperlipidemia) 01/2024 - 09/2010
2	Aortic Dissection 01/2023 - 08/2021
2	Chronic Kidney Failure (Chronic Renal Failure) 06/2022 - 01/2018
2	Obesity 01/2022 - 03/2006
2	Venous Thromboembolism 01/2022 - 06/2008
2	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2019 - 04/2016
2	Neoplasms (Cancer) 01/2019 - 05/2013

Drug/Important Bio-Agent (IBA)

75	RivaroxabanIBA 05/2024 - 06/2008
60	Warfarin (Coumadin)FDA LinkGeneric 01/2024 - 09/2009
42	Vitamin K FDA Link 01/2024 - 01/2013
35	Factor Xa (Coagulation Factor Xa)IBA 01/2023 - 02/2012
28	TicagrelorIBA 01/2022 - 06/2015
24	Clopidogrel (Plavix)FDA Link 12/2022 - 04/2004
23	omega-Chloroacetophenone (Mace)IBA 01/2024 - 01/2016
19	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 05/2024 - 01/2002
19	AnticoagulantsIBA 01/2024 - 02/2012
11	pexelizumabIBA 11/2013 - 03/2005
9	CreatinineIBA 01/2023 - 05/2012
7	Biomarkers (Surrogate Marker)IBA 06/2015 - 12/2004
6	apixabanIBA 02/2024 - 01/2016
6	Factor Xa InhibitorsIBA 01/2022 - 10/2011
5	N(4)-oleylcytosine arabinosideIBA 01/2024 - 01/2016
5	LipidsIBA 10/2022 - 01/2008
5	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 12/2021 - 12/2014
5	Insulin (Novolin)FDA Link 10/2021 - 03/2010
4	TroponinIBA 01/2022 - 09/2010
3	pro-brain natriuretic peptide (1-76)IBA 01/2024 - 08/2010
3	LDL CholesterolIBA 01/2023 - 12/2020
3	Hemoglobins (Hemoglobin)IBA 12/2021 - 10/2019
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2015 - 09/2010
3	MetalsIBA 10/2012 - 01/2009
2	Indicators and Reagents (Reagents)IBA 10/2023 - 01/2019
2	Glucagon-Like Peptide 1 (GLP 1)IBA 03/2023 - 12/2019
2	oxidized low density lipoproteinIBA 01/2023 - 01/2021
2	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 12/2022 - 01/2016
2	Tissue Plasminogen Activator (Alteplase)FDA Link 12/2022 - 11/2017
2	Thrombin Receptors (Thrombin Receptor)IBA 01/2022 - 10/2014
2	Paclitaxel (Taxol)FDA LinkGeneric 11/2021 - 01/2021

Therapy/Procedure

64	Therapeutics 12/2023 - 01/2002
41	Percutaneous Coronary Intervention 02/2024 - 05/2007
40	Surgical Amputation (Amputations) 01/2024 - 11/2012
10	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2019 - 03/2005
8	Counterpulsation (External Counterpulsation) 01/2019 - 07/2011
6	Stents 01/2019 - 09/2006
4	Secondary Prevention 01/2022 - 06/2008
4	Electric Countershock (Cardioversion) 01/2018 - 05/2013
3	Drug Therapy (Chemotherapy) 06/2021 - 05/2013
3	Contraindications 01/2021 - 03/2017
3	Enzyme Replacement Therapy 01/2016 - 03/2011
3	Critical Care (Surgical Intensive Care) 09/2012 - 05/2012
3	Drug-Eluting Stents 05/2012 - 05/2007
2	Endovascular Aneurysm Repair 01/2023 - 08/2021
2	Renal Dialysis (Hemodialysis) 06/2022 - 01/2016
2	Endovascular Procedures 07/2020 - 04/2011
2	Myocardial Revascularization 01/2020 - 01/2018